Our analysis of the ISR and mTOR protein translation pathways in these samples showed that the ISR marker ATF4 is highly expressed in OLs in the active areas of MS lesions, whereas there is reduced expression of the mTOR pathway marker p4E-BP1. This evidence concerns the gene ATF4 and myeloid sarcoma.